/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

T

Thomas E. Mürdter

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

179

Papers

4.4K

Citations

36

h-index

83

i10-index

Thomas E. Mürdter is an academic researcher from Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Estrogen and related hormone effects & Cancer, Hypoxia, and Metabolism. The author has an h-index of 36, co-authored 153 publications.

ORCID: 0000-0002-8786-8122

Research Topics

Pharmacogenetics and Drug Metabolism Estrogen and related hormone effects Cancer, Hypoxia, and Metabolism Advanced Breast Cancer Therapies Inflammatory mediators and NSAID effects

Papers by this author

works

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy

2013 · Annals of Surgical Oncology · 367 citations

https://doi.org/10.1245/s10434-013-3213-1

Wiebke Solaß Reinhold Kerb Thomas E. Mürdter Urs Giger-Pabst

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

2014 · The Pharmacogenomics Journal · 197 citations

https://doi.org/10.1038/tpj.2014.34

Pilar H. Saladores Thomas E. Mürdter Diana Eccles Balram Chowbay

P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans

2003 · Clinical Pharmacology & Therapeutics · 158 citations

https://doi.org/10.1067/mcp.2003.27

Siegfried Drescher Hartmut Glaeser Thomas E. Mürdter Monika Hitzl

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

2006 · BMC Cancer · 110 citations

https://doi.org/10.1186/1471-2407-6-86

Heiko van der Kuip Thomas E. Mürdter Maike Sonnenberg Monika McClellan

Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts

2010 · Molecular Cancer · 78 citations

https://doi.org/10.1186/1476-4598-9-168

Silke Haubeiß Jens O. Schmid Thomas E. Mürdter Maike Sonnenberg

Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor–Positive Breast Cancer Patients

2020 · Clinical Cancer Research · 43 citations

https://doi.org/10.1158/1078-0432.ccr-20-1923

Werner Schroth Florian Büttner Siarhei Kandabarau Reiner Hoppe

Research topics

topics

Pharmacogenetics and Drug Metabolism

Estrogen and related hormone effects

Cancer, Hypoxia, and Metabolism

Advanced Breast Cancer Therapies

Inflammatory mediators and NSAID effects

Chat about Author

Papers

Chat

Click to start Chat